Avandia on Trial

The Type 2 diabetes drug rosiglitazone (brand name Avandia) has had a rough history — beginning with a study three years ago that found a 43% higher risk of heart attack associated with the drug, and recently as the focus of a report by the US Senate Finance Committee that accused GlaxoSmithKline, Avandia’s manufacturer, of intimidating physicians and playing down the cardiovascular risk posed by the drug. Glaxo has long maintained that Avandia is safe and remains an important option for doctors and patients. But if a consumer advocacy group has its way, Glaxo will not get another chance to prove Avandia’s safety.


Glaxo is currently beginning a massive study of Avandia, comparing it with competitor drug pioglitazone (Actos), called TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation). According to an article from Reuters, the trial aims to study 16,000 people before the year 2015, using 137 locations in 14 countries. The trial was requested three years ago by the US Food and Drug Administration in response to the first allegations of a higher cardiovascular risk associated with Avandia. Since then, however, more evidence of Avandia’s heart risk has emerged, prompting the nonprofit group Public Citizen to call for an end to the TIDE trial, calling it “unethical” and “dangerous,” according to a post on the Los Angeles Times blog Booster Shots. In a letter to FDA Commissioner Margaret Hamburg, Public Citizen argues that TIDE will most likely not produce more reliable evidence than already exists, yet exposes thousands of people already at high risk for heart problems to a drug known to increase that risk.

This renewed controversy comes at the same time as reports that Glaxo has settled hundreds of claims alleging that Avandia caused heart attacks or other cardiovascular problems. The total settlement is said to be around $60 million, considered to be a small amount. However, an upcoming court case involving thousands of claims could result in a much greater settlement.

In a published statement, Glaxo stressed that the board overseeing TIDE “has not expressed any concerns regarding the safety of participants in the study and has recommended that the study continue without modification.” And a spokesperson for the company noted that Avandia has been shown to control blood glucose levels for up to five years.

The FDA is currently reviewing the data on Avandia, and an advisory panel is planning to meet in July to discuss the drug’s safety. It seems unlikely, however, that the FDA will stop TIDE; the agency has specifically called for more data to evaluate Avandia, which the trial aims to provide.

What do you think — is it ethical to randomly assign a drug with safety concerns to trial participants? Would you participate in the TIDE trial? Is the FDA right to want definitive evidence of Avandia’s risks, compared with Actos? How much risk should be considered acceptable in a Type 2 diabetes drug, given the alternatives available? Leave a comment below!

Learn more about the health and medical experts who who provide you with the cutting-edge resources, tools, news, and more on Diabetes Self-Management.
About Our Experts >>

  • Dale A.

    definately that drug should be studied more. I took the drug back in about 2005. I felt terrible the intire time. My chest felt heavy and I felt as though my stomacjh had a tumor. I requested to be taken off the drug. This was during a study I was doing in Minneapolis at the Int’l Diabetes Center at Park Nicollet for ACCORD.

    I also had a friend and she was on it and while she was her ankle looked absolutely huge. She also requested that she be removed from the drug. I do not believe that is a safe drug for alot of individuals.

    It needs to be scrutinized closely

  • Dee

    I started taking Avandia when it ws first released and approved by FDA. I see my endocronologist every 3 months and he besides my A1C he does cholestrol, etc. In 2006 I had a stroke, although my A1C was uner 7.0, my cholestrol, LDL and triglycerides, my blood pressure, etc. were all within normal range. I had no other risk factors other than taking avandia!!!

  • Lorraine

    I would like to know how old Dee was when she had the stroke. Thank you, Regards

  • Andrew Molina

    I was taking Avandia and in 1992 I was told by my Doctor to stop taking Avandia when she discovered I had “HEART FAILURE”.

  • Shirley Taylor

    I started taking Avandia in 2005 and still take it. I have had no problems.